1
00:00:00,080 --> 00:00:02,720
Speaker 1: Because we do know that. Obviously, the government has this

2
00:00:02,759 --> 00:00:06,440
Speaker 1: morning announced as Territorians aged eighteen and over will have

3
00:00:06,559 --> 00:00:09,719
Speaker 1: the opportunity to start booking their COVID nineteen booster shot

4
00:00:09,760 --> 00:00:13,319
Speaker 1: appointments well from this morning. So joining me on the

5
00:00:13,360 --> 00:00:16,480
Speaker 1: line is Professor Bavini Patel. Good morning to you.

6
00:00:17,360 --> 00:00:18,239
Speaker 2: Hello, how are you?

7
00:00:18,440 --> 00:00:21,040
Speaker 1: Yeah? Very well? Thank you. Now, professor, what is the

8
00:00:21,079 --> 00:00:23,440
Speaker 1: situation with the booster who's eligible?

9
00:00:24,840 --> 00:00:28,920
Speaker 2: So, as you said, any any person over the age

10
00:00:28,960 --> 00:00:33,520
Speaker 2: of eighteen is eligible for a booster six months after

11
00:00:33,600 --> 00:00:35,360
Speaker 2: they received their second dose.

12
00:00:36,040 --> 00:00:38,519
Speaker 1: Okay, so you do have to wait that six months

13
00:00:38,560 --> 00:00:41,760
Speaker 1: after you received your second dose Brevini. Doesn't matter whether

14
00:00:41,760 --> 00:00:44,200
Speaker 1: you had the Astrosenica or the Pfizer.

15
00:00:44,760 --> 00:00:49,480
Speaker 2: No, it doesn't matter. So the eligibility is six months

16
00:00:49,560 --> 00:00:55,160
Speaker 2: after your any second dose that you received, whether it's Astrasenka,

17
00:00:55,200 --> 00:00:59,320
Speaker 2: PISA or now with the other vaccine, the Maderna vaccine

18
00:00:59,360 --> 00:00:59,840
Speaker 2: as well.

19
00:01:00,600 --> 00:01:03,480
Speaker 1: And how come it's not sort of being rolled out

20
00:01:03,560 --> 00:01:07,760
Speaker 1: to the elderly or the vulnerable first.

21
00:01:07,480 --> 00:01:09,480
Speaker 2: Well, it sort of is. If you think about the

22
00:01:09,520 --> 00:01:13,760
Speaker 2: campaign that we've had with the different phases. So if

23
00:01:13,800 --> 00:01:17,160
Speaker 2: we call all the way back in February, we had

24
00:01:17,319 --> 00:01:21,560
Speaker 2: the Phase one A people who were the elderly people

25
00:01:21,600 --> 00:01:26,360
Speaker 2: working in quarantine or health and emergency services workers who

26
00:01:26,440 --> 00:01:29,800
Speaker 2: had a higher risk of being exposed to COVID. They

27
00:01:29,800 --> 00:01:34,479
Speaker 2: all got their vaccines early in March, April, and May,

28
00:01:35,080 --> 00:01:38,880
Speaker 2: and so by definition they'll become eligible for the booster

29
00:01:39,840 --> 00:01:43,399
Speaker 2: six months time. So they will be the first people

30
00:01:43,400 --> 00:01:46,640
Speaker 2: who are eligible. And those people are eligible now, which

31
00:01:46,720 --> 00:01:53,080
Speaker 2: is why we're encouraging that cohort to make an arrangements

32
00:01:53,120 --> 00:01:53,840
Speaker 2: to have a booster.

33
00:01:54,480 --> 00:01:57,640
Speaker 1: And so in terms of you know, for those people

34
00:01:57,680 --> 00:02:00,600
Speaker 1: who did have let's say they had the astroseny to

35
00:02:00,680 --> 00:02:04,120
Speaker 1: begin with six months ago or even longer, is it's

36
00:02:04,200 --> 00:02:06,880
Speaker 1: okay to not be sort of going on with the

37
00:02:07,040 --> 00:02:09,320
Speaker 1: same type of vaccine for the third shot.

38
00:02:10,240 --> 00:02:15,000
Speaker 2: Yeah. So there's some been some really good clinical trials

39
00:02:15,080 --> 00:02:20,280
Speaker 2: in the Northern hemisphere that have asked the question about

40
00:02:20,320 --> 00:02:24,280
Speaker 2: what is the right approach for a booster vaccine program

41
00:02:24,360 --> 00:02:28,760
Speaker 2: for COVID nineteen and the studies have shown that using

42
00:02:28,800 --> 00:02:35,280
Speaker 2: a messenger RNA vaccine like Pfizer, regardless of what your

43
00:02:35,360 --> 00:02:40,200
Speaker 2: original vaccine was, is safe and effective as a booster program.

44
00:02:40,919 --> 00:02:44,320
Speaker 1: Are they phasing out the astrosenica or is it still

45
00:02:44,400 --> 00:02:46,600
Speaker 1: being delivered throughout the nation.

46
00:02:47,760 --> 00:02:53,640
Speaker 2: AstraZeneca vaccine continues to be available through community pharmacies and

47
00:02:53,800 --> 00:02:59,680
Speaker 2: general practice, so people now have choice in terms of

48
00:02:59,760 --> 00:03:03,520
Speaker 2: which vaccine they get for their primary course. So if

49
00:03:03,560 --> 00:03:06,840
Speaker 2: people haven't had their first and second doses, they now

50
00:03:06,919 --> 00:03:09,960
Speaker 2: have a choice of three vaccines. And then those of

51
00:03:10,040 --> 00:03:14,680
Speaker 2: us who are already fully vaccinated will become eligible if

52
00:03:14,680 --> 00:03:18,080
Speaker 2: we're eighteen years and over six months after your second dose.

53
00:03:18,680 --> 00:03:21,160
Speaker 1: Be any question that's just come through from a listener,

54
00:03:21,200 --> 00:03:23,400
Speaker 1: when are the twelve and over is going to be

55
00:03:23,560 --> 00:03:25,480
Speaker 1: eligible for the booster? I know a lot of them

56
00:03:25,520 --> 00:03:28,280
Speaker 1: are probably only just received theirs, but when will they

57
00:03:28,360 --> 00:03:29,040
Speaker 1: be eligible?

58
00:03:29,840 --> 00:03:35,080
Speaker 2: So currently the clinical studies show that in people under

59
00:03:35,120 --> 00:03:41,160
Speaker 2: the age of eighteen, the immune system responds really well

60
00:03:41,200 --> 00:03:46,240
Speaker 2: to the two two dose course of the vaccine, and

61
00:03:46,280 --> 00:03:49,520
Speaker 2: so at this stage there's no studies to show that

62
00:03:49,520 --> 00:03:52,680
Speaker 2: that age group will need a booster. But as with

63
00:03:52,800 --> 00:03:59,120
Speaker 2: everything with the COVID nineteen disease, we're learning lessons every

64
00:03:59,160 --> 00:04:04,800
Speaker 2: month and sharing information right across Australia and also with

65
00:04:04,920 --> 00:04:10,360
Speaker 2: our international colleagues. So at this stage children and young

66
00:04:10,400 --> 00:04:14,240
Speaker 2: people under the age of eighteen do not need a booster,

67
00:04:14,760 --> 00:04:15,440
Speaker 2: So why.

68
00:04:15,320 --> 00:04:18,080
Speaker 1: Is it that those over the age of eighteen actually

69
00:04:18,120 --> 00:04:18,880
Speaker 1: need that booster.

70
00:04:20,400 --> 00:04:24,080
Speaker 2: That's quite a complicated question, Katie. So in terms of

71
00:04:24,240 --> 00:04:28,440
Speaker 2: our immune system, we know as we get older, our

72
00:04:28,480 --> 00:04:31,880
Speaker 2: immune system, like everything else, doesn't work as well as

73
00:04:31,880 --> 00:04:37,359
Speaker 2: when we're younger. And the studies are showing that the

74
00:04:37,440 --> 00:04:43,200
Speaker 2: risk benefit of needing a booster is required in people

75
00:04:43,200 --> 00:04:46,760
Speaker 2: over the age of eighteen and not for young people

76
00:04:46,839 --> 00:04:47,960
Speaker 2: under the age of eighteen.

77
00:04:48,560 --> 00:04:50,880
Speaker 1: I know, I've heard some people in the community say,

78
00:04:51,560 --> 00:04:54,520
Speaker 1: you know, well, this is proof that the vaccine doesn't work.

79
00:04:57,600 --> 00:05:02,200
Speaker 2: Well, that's an interesting and our so people might know that,

80
00:05:03,040 --> 00:05:06,000
Speaker 2: especially people with young kids, that we've got lots of

81
00:05:06,040 --> 00:05:11,120
Speaker 2: different vaccines that we use to keep young people and

82
00:05:11,680 --> 00:05:16,640
Speaker 2: adults safe from a variety of infectious diseases. And each

83
00:05:16,720 --> 00:05:22,080
Speaker 2: vaccine has its own schedule, and so some vaccines you

84
00:05:22,200 --> 00:05:27,280
Speaker 2: need two or three doses over a short period of time,

85
00:05:27,400 --> 00:05:30,640
Speaker 2: so you know, over six to twelve months, and then

86
00:05:30,680 --> 00:05:34,279
Speaker 2: other vaccines you need a much longer period of time

87
00:05:34,760 --> 00:05:38,800
Speaker 2: where you give repeated boosters. So if you think about

88
00:05:39,120 --> 00:05:43,240
Speaker 2: the influenza vaccine, to protect you from the flu, we

89
00:05:43,360 --> 00:05:45,640
Speaker 2: need to have a booster every year.

90
00:05:46,080 --> 00:05:46,320
Speaker 1: Yep.

91
00:05:47,160 --> 00:05:49,480
Speaker 2: With your Teennus vaccine, you need to have a booster

92
00:05:49,560 --> 00:05:53,760
Speaker 2: every ten years. For your hepatitis B vaccine, you need

93
00:05:53,839 --> 00:05:56,440
Speaker 2: to have a course of three vaccines over a period

94
00:05:56,440 --> 00:06:00,200
Speaker 2: of time. So, as I said with the COVID, with

95
00:06:00,279 --> 00:06:04,360
Speaker 2: the COVID nineteen disease, because it's a new disease, we're

96
00:06:04,440 --> 00:06:09,640
Speaker 2: learning our lessons and so it's not unusual that after

97
00:06:09,680 --> 00:06:14,599
Speaker 2: your primary couple of doses for other diseases that you

98
00:06:14,680 --> 00:06:15,600
Speaker 2: do need a top up.

99
00:06:15,760 --> 00:06:18,960
Speaker 1: Yeah, Bevini, Can I ask or know that we always

100
00:06:19,000 --> 00:06:22,560
Speaker 1: get plenty of messages from people wondering where we're at

101
00:06:22,640 --> 00:06:24,960
Speaker 1: with the novavax vaccine. Yes.

102
00:06:25,279 --> 00:06:30,440
Speaker 2: Yes, people are quite interested in a novovac. So you

103
00:06:30,520 --> 00:06:32,840
Speaker 2: might recall I think we had a conversation about this

104
00:06:32,880 --> 00:06:37,800
Speaker 2: a few weeks. Yeah, and so nothing has changed in

105
00:06:37,920 --> 00:06:44,599
Speaker 2: terms of a Australian application from the company that makes novovacs.

106
00:06:45,040 --> 00:06:50,680
Speaker 2: As I said last time, the TGA, our Medicines regulator

107
00:06:50,720 --> 00:06:54,160
Speaker 2: in Australia did give the green light to the company

108
00:06:54,320 --> 00:06:58,200
Speaker 2: to put in an application at the beginning of this year.

109
00:06:58,760 --> 00:07:02,279
Speaker 2: The company has not yet put in an application, and

110
00:07:02,360 --> 00:07:06,800
Speaker 2: so I would really encourage people who are not yet

111
00:07:06,880 --> 00:07:10,800
Speaker 2: booked in for their vaccine that they do that as

112
00:07:10,800 --> 00:07:15,560
Speaker 2: soon as possible, because it's unlikely that will get novovacs

113
00:07:16,360 --> 00:07:20,600
Speaker 2: registered for use in Australia anytime in the near future

114
00:07:20,680 --> 00:07:23,680
Speaker 2: because there's still no application bevini.

115
00:07:24,000 --> 00:07:26,680
Speaker 1: From your perspective, how is that role out going at

116
00:07:26,680 --> 00:07:29,600
Speaker 1: this point in time? I know that when that mandate

117
00:07:29,680 --> 00:07:31,840
Speaker 1: was first announced it seemed as though there was a

118
00:07:31,880 --> 00:07:33,720
Speaker 1: bit of a rush from some to go and get

119
00:07:34,120 --> 00:07:36,840
Speaker 1: the vaccine. How is the role out going at this point?

120
00:07:37,960 --> 00:07:39,480
Speaker 2: So if we have a look at the numbers on

121
00:07:39,520 --> 00:07:45,760
Speaker 2: our website, we're tracking at eighty eight percent of Territorians

122
00:07:46,680 --> 00:07:50,920
Speaker 2: having received their first dose, which is great. It's been

123
00:07:50,960 --> 00:07:54,440
Speaker 2: a great response to the Chief Minister and the Chief

124
00:07:54,480 --> 00:08:02,920
Speaker 2: Health Officer's announcements and we're continuing to work right across

125
00:08:02,960 --> 00:08:08,480
Speaker 2: the NT community by community, you know, having conversations with

126
00:08:09,200 --> 00:08:17,040
Speaker 2: sporting groups, with the multicultural community, with Aboriginal community organizations

127
00:08:17,040 --> 00:08:22,600
Speaker 2: to really understand and have individual conversations to understand what

128
00:08:22,720 --> 00:08:25,240
Speaker 2: people are still worried about that stopping them from getting

129
00:08:25,240 --> 00:08:30,560
Speaker 2: a vaccine and trying to provide that credible and trustworthy

130
00:08:30,640 --> 00:08:34,600
Speaker 2: advice to answer those concerns. And you know, we're really

131
00:08:34,640 --> 00:08:38,400
Speaker 2: looking to get well into the ninety percent YEP for

132
00:08:38,520 --> 00:08:43,439
Speaker 2: fully vaccination, for full vaccinations right across the NT can.

133
00:08:43,280 --> 00:08:46,640
Speaker 1: I ask a few callers coming through asking if boosters

134
00:08:46,640 --> 00:08:49,040
Speaker 1: are going to be required sort of ongoing, if it's

135
00:08:49,040 --> 00:08:51,880
Speaker 1: potentially something that we're going to need every six months

136
00:08:51,960 --> 00:08:52,560
Speaker 1: or every year.

137
00:08:53,880 --> 00:08:57,840
Speaker 2: So at this stage we don't know the answer to that. Christian.

138
00:08:57,880 --> 00:09:00,079
Speaker 2: When I say we, I am talking about the medical and

139
00:09:00,160 --> 00:09:09,560
Speaker 2: scientific collective community. So ongoing studies are happening across the

140
00:09:09,559 --> 00:09:12,800
Speaker 2: Northern Hemisphere because we're learning lots of lessons from Europe

141
00:09:12,840 --> 00:09:17,400
Speaker 2: and America and the UK. As you know, they're a

142
00:09:17,480 --> 00:09:19,920
Speaker 2: little bit ahead of us, and so we'll keep an

143
00:09:19,960 --> 00:09:26,640
Speaker 2: eye on those studies and if it looks like additional

144
00:09:26,720 --> 00:09:30,440
Speaker 2: booster doses are required, then we'll certainly review that need.

145
00:09:30,440 --> 00:09:34,400
Speaker 1: In Australia, Beveni obviously had said that there is work

146
00:09:34,480 --> 00:09:37,520
Speaker 1: underway in some of those different areas, some locations where

147
00:09:37,520 --> 00:09:40,560
Speaker 1: people have been hesitantal or they're not wanting to get

148
00:09:40,559 --> 00:09:44,800
Speaker 1: the vaccine. Are you finding it frustrating that some territorians

149
00:09:44,960 --> 00:09:47,280
Speaker 1: are not listening to the science and not listening to

150
00:09:47,320 --> 00:09:50,079
Speaker 1: the medical advice and more going down the path of

151
00:09:50,800 --> 00:09:54,800
Speaker 1: listening to things that they're being told on social media.

152
00:09:54,960 --> 00:09:58,360
Speaker 2: I don't think. I don't think frustrations the right emotion.

153
00:09:59,160 --> 00:10:02,600
Speaker 2: I think I think what we're doing, both in the

154
00:10:02,600 --> 00:10:06,080
Speaker 2: health system and also with all those community partners that

155
00:10:06,600 --> 00:10:12,040
Speaker 2: I described before, is really having a listening ear and

156
00:10:12,080 --> 00:10:16,120
Speaker 2: creating a safe space for people to understand or raise

157
00:10:16,160 --> 00:10:22,560
Speaker 2: their concerns with people who understand the science, understand the

158
00:10:22,640 --> 00:10:28,760
Speaker 2: clinical impacts of COVID as a serious disease, and then

159
00:10:29,240 --> 00:10:34,880
Speaker 2: help people reflect on the benefits of both to themselves,

160
00:10:35,600 --> 00:10:39,079
Speaker 2: their families and the broader anti community of getting the

161
00:10:39,160 --> 00:10:40,640
Speaker 2: vaccine well.

162
00:10:40,679 --> 00:10:44,640
Speaker 1: Professor Bavini Patel, the vaccine lead here in the Northern Territory,

163
00:10:44,640 --> 00:10:46,920
Speaker 1: I always appreciate your time. I know you're very busy.

164
00:10:46,960 --> 00:10:48,960
Speaker 1: Thanks so much for having a chat with us this morning.

165
00:10:49,600 --> 00:10:50,880
Speaker 2: Lovely to talk to you, Katie.

166
00:10:51,160 --> 00:10:52,000
Speaker 1: Thank you you too,